Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
134
0
10

Year Published

2022
2022
2023
2023

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 152 publications
(146 citation statements)
references
References 42 publications
2
134
0
10
Order By: Relevance
“…Indeed, AFE is a self-resolving disease affecting the pulmonary and cardiovascular systems with most death and complications occurring during the first 24 h [ 1 ]. Our results reinforce that high bleeding risk should not be seen as an absolute contraindication to use ECMO [ 23 ]. However, ECMO management should be wisely adapted to these complex situations with DIC, thrombocytopenia, and frequent ongoing bleeding.…”
Section: Discussionsupporting
confidence: 86%
“…Indeed, AFE is a self-resolving disease affecting the pulmonary and cardiovascular systems with most death and complications occurring during the first 24 h [ 1 ]. Our results reinforce that high bleeding risk should not be seen as an absolute contraindication to use ECMO [ 23 ]. However, ECMO management should be wisely adapted to these complex situations with DIC, thrombocytopenia, and frequent ongoing bleeding.…”
Section: Discussionsupporting
confidence: 86%
“…Lower limb ischemia is a potentially life-threatening complication of peripheral femoral VA-ECMO and various risk factors-namely younger age, female sex, underlying peripheral arterial disease, larger (>20 Fr) arterial cannulas, absence of distal perfusion catheter-have been identified over time. 27,28,30 17 However, the percutaneous approach has been increasingly used in the last decade. Interestingly, percutaneous cannulation for peripheral VA-ECMO was associated with fewer local infections, similar rates of limb ischemia during support and higher rate of vascular complications following decannulation as compared to the surgical approach in a recent propensity score-matched analysis from a very large-volume VA-ECMO center.…”
Section: Discussionmentioning
confidence: 99%
“…Vascular repletion with fluid administration was often required to correct capillary leak. The adequacy of the hemodynamic support provided by VA‐ECMO was monitored with arterial and central venous pressures, urine output, mixed venous oxygen saturation and blood lactate 17 . The anticoagulation protocol targeted an anti‐Xa factor activity between 0.30 and 0.70 IU/ml during VA‐ECMO support.…”
Section: Methodsmentioning
confidence: 99%
“…Venous-arterial extracorporeal membrane oxygenation (VA ECMO) is a temporary mechanical circulatory support device that provides circulatory and respiratory support for patients with cardiogenic shock (1)(2)(3)(4). However, complications, such as hemorrhage, infection, and acute kidney injury, may occur during VA ECMO support and are associated with poor outcomes (5).…”
Section: Introductionmentioning
confidence: 99%